Hepatic Encephalopathy: When Lactulose and Rifaximin Are Not Working
- 24 January 2025
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 168 (6) , 1076-1084.e1
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- L‐ornithine L‐aspartate in acute treatment of severe hepatic encephalopathy: A double‐blind randomized controlled trialHepatology, 2021
- The Use of Rifaximin in Patients With CirrhosisHepatology, 2021
- Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled TrialHepatology, 2019
- Prognostic Role of Ammonia in Patients With CirrhosisHepatology, 2019
- Association Between Cirrhosis and Stroke in a Nationally Representative CohortJAMA Neurology, 2017
- Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trialHepatology, 2017
- Nonabsorbable disaccharides for hepatic encephalopathy: A systematic review and meta‐analysisHepatology, 2016
- The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensusHepatology, 2013
- Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: A multicenter survey on safety and efficacyHepatology, 2013
- Smoking-related morbidity and mortality following liver transplantationLiver Transplantation, 2008